C Tripodo
Overview
Explore the profile of C Tripodo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
476
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malinverno M, Callegari E, Pirona L, Pellerani I, Belmonte B, Tripodo C, et al.
Eur Rev Med Pharmacol Sci
. 2023 Sep;
27(17):8269-8279.
PMID: 37750654
Objective: Hemorrhoids are a common anorectal disease that causes pain, itching, and burning. The prevalence of hemorrhoids is estimated to be as high as 36% in the general population, with...
2.
Cortellino S, Quagliariello V, Delfanti G, Blazevits O, Chiodoni C, Maurea N, et al.
Nat Commun
. 2023 Sep;
14(1):5529.
PMID: 37684243
Immune checkpoint inhibitors cause side effects ranging from autoimmune endocrine disorders to severe cardiotoxicity. Periodic Fasting mimicking diet (FMD) cycles are emerging as promising enhancers of a wide range of...
3.
Chiodoni C, Sangaletti S, Lecchi M, Ciniselli C, Cancila V, Tripodi I, et al.
ESMO Open
. 2023 Jul;
8(4):101590.
PMID: 37393630
Background: Gene expression profiling (GEP)-based prognostic signatures are being rapidly integrated into clinical decision making for systemic management of breast cancer patients. However, GEP remains relatively underdeveloped for locoregional risk...
4.
Di Napoli A, Remotti D, Agostinelli C, Ambrosio M, Ascani S, Carbone A, et al.
Virchows Arch
. 2019 Oct;
475(6):799.
PMID: 31664506
The first and family names of the authors were interchanged and are now presented correctly. The original article has been corrected.
5.
Ciavarella S, Vegliante M, Fabbri M, De Summa S, Melle F, Motta G, et al.
Ann Oncol
. 2019 Sep;
30(12):2015.
PMID: 31539020
No abstract available.
6.
Di Napoli A, Remotti D, Agostinelli C, Ambrosio M, Ascani S, Carbone A, et al.
Virchows Arch
. 2019 Aug;
475(4):513-518.
PMID: 31388760
An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is crucial for the choice of proper treatment. Presently, precise recognition of these disorders relies on the...
7.
De Santis F, Del Vecchio M, Castagnoli L, de Braud F, Di Cosimo S, Franceschini D, et al.
Cytokine Growth Factor Rev
. 2018 Nov;
44:1-10.
PMID: 30393044
The eighth annual conference of "Innovative therapy, monoclonal antibodies, and beyond" was held in Milan on Jan. 26, 2018, and hosted by Fondazione IRCCS-Istituto Nazionale dei Tumori (Fondazione IRCCS INT)....
8.
Ciavarella S, Vegliante M, Fabbri M, De Summa S, Melle F, Motta G, et al.
Ann Oncol
. 2018 Oct;
29(12):2363-2370.
PMID: 30307529
Background: Gene expression profiling (GEP) studies recognized a prognostic role for tumor microenvironment (TME) in diffuse large B-cell lymphoma (DLBCL), but the routinely adoption of prognostic stromal signatures remains limited....
9.
Felli N, Errico M, Pedini F, Petrini M, Puglisi R, Bellenghi M, et al.
Oncogene
. 2015 Oct;
35(23):3016-26.
PMID: 26434590
Accumulating evidences have shown the association between aberrantly expressed microRNAs (miRs) and cancer, where these small regulatory RNAs appear to dictate the cell fate by regulating all the main biological...
10.
Laginestra M, Piccaluga P, Fuligni F, Rossi M, Agostinelli C, Righi S, et al.
Blood Cancer J
. 2014 Nov;
4:259.
PMID: 25382608
Peripheral T-cell lymphomas not otherwise specified (PTCLs/NOS) are rare and aggressive tumours whose molecular pathogenesis and diagnosis are still challenging. The microRNA (miRNA) profile of 23 PTCLs/NOS was generated and...